St. Louis campaign puts women’s cardiovascular risk back in focus
The American Heart Association is using its St. Louis Go Red for Women campaign to push a blunt message: cardiovascular disease still kills more women than any other condition, and many women remain unaware of how much that risk changes across the lifespan. The local effort will be led by Holly Francois, chief financial officer of Maritz, who will serve as chair for the 2026-27 St. Louis initiative. Her role is meant to keep the message visible outside hospital walls, where risk awareness often lags behind the biology.
A recent American Heart Association projection gives the campaign added urgency. By 2050, almost 60% of women could have high blood pressure. Hypertension is not a background problem in women’s health; it is one of the strongest drivers of stroke, heart failure, kidney injury, and coronary disease. When blood pressure rises and stays elevated, the arterial wall is subjected to chronic mechanical stress, endothelial dysfunction accelerates, and the downstream burden of vascular injury spreads quietly long before symptoms appear.
Awareness gaps still leave many women unprotected
Francois framed the campaign in direct terms, arguing that women’s health should not be treated as a trend or a buzzword. Her comments mirror a stubborn public health problem: less than half of women are aware of their unique cardiovascular risk. In practical terms, that means too many women enter midlife, pregnancy, menopause, and older age without a clear understanding of how blood pressure, diabetes, lipids, smoking, inactivity, pregnancy-related complications, and family history can compound over time.
The gap is not only informational. It is behavioral and structural. Many women spend years prioritizing family, work, and caregiving while their own preventive care is deferred until a crisis forces the issue. In cardiovascular medicine, delay is rarely neutral. A woman who ignores persistent hypertension, for example, does not simply “hold steady”; vascular remodeling continues, the heart works harder against increasing afterload, and risk accumulates silently until the first major event arrives.
Francois said women often put themselves last while caring for families, careers, and communities. That observation reflects a familiar pattern in preventive cardiology: symptoms are minimized, appointments are postponed, and early warning signs are normalized. For women, especially, that can be dangerous because cardiovascular symptoms may not present in the classic textbook form that many patients expect.
Go Red for Women aims to close research and care gaps
Go Red for Women is built around more than awareness messaging. The campaign is designed to educate women about risk factors at every stage of life while addressing gaps in research and health care access. Its goal is to help women understand their risk, advocate for themselves, and take concrete steps that can improve long-term heart and brain health.
That combination matters because women have historically been underrepresented in cardiovascular research and often undertreated in routine care. A prevention strategy that ignores sex-specific risk patterns misses a key biological and clinical reality. Hormonal transitions, pregnancy complications, and age-related shifts in blood pressure and metabolic risk can alter a woman’s trajectory in ways that standard one-size-fits-all messaging does not capture. Better awareness can lead to earlier diagnosis, more timely treatment, and more consistent use of proven preventive measures.
The campaign also leans on community support. That social layer is not cosmetic. For many women, a trusted environment makes it easier to ask questions, discuss family history, and act on abnormal readings before end-organ damage sets in. Community-based initiatives can also help normalize blood pressure screening, nutrition counseling, physical activity, and medical follow-up as routine parts of care rather than as emergency responses.
Blood pressure projections point to a worsening burden
The projected rise in hypertension among women by 2050 raises the stakes for every local prevention effort. Blood pressure remains one of the most modifiable cardiovascular risk factors, yet it is also one of the most commonly overlooked. In a population where nearly six in 10 women may be living with high blood pressure by midcentury, the burden of untreated or undertreated disease would extend across emergency departments, stroke units, cardiology clinics, and primary care practices.
Francois’ chairmanship brings a business and community leadership voice to a clinical issue that often requires both. Public health messages rarely change behavior on their own; they need repetition, local credibility, and a clear path to action. Events such as the St. Louis Go Red for Women Luncheon are meant to translate risk awareness into engagement, bringing survivors, advocates, and attendees into the same room around a single clinical priority: preventing avoidable cardiovascular disease in women.
The luncheon is scheduled for April 30, 2027, at the Ritz Carlton St. Louis and will include survivor stories and an interactive pop-up lounge centered on heart health action. Those elements are more than ceremonial. Survivor testimony gives face and voice to a disease that is often hidden until it is advanced, while hands-on education can make risk feel concrete enough to change behavior.
A local chairmanship with national clinical relevance
The St. Louis effort is locally sponsored by Maritz, but the implications are broader than one city’s calendar. Every community campaign that improves blood pressure awareness, screens more women, or nudges someone into preventive care has the potential to prevent a future heart attack or stroke. For clinicians, the message is straightforward: women need repeated, specific counseling about cardiovascular risk, not generic reassurance.
For patients, the clinical takeaway is even more direct. Symptoms should not be waited out, blood pressure should not be ignored, and family history should not be treated as an abstract detail. When women understand that heart disease remains the leading cause of death in their demographic, prevention becomes a personal medical priority rather than a distant statistic.
The unresolved challenge is scale. Awareness campaigns can open the door, but they do not by themselves fix screening gaps, research inequities, or inconsistent access to treatment. Those are the problems that determine whether projected hypertension trends will actually translate into more strokes, more heart failure, and more premature deaths in women over the next quarter century.